{"id":30875,"date":"2022-01-31T10:24:15","date_gmt":"2022-01-31T10:24:15","guid":{"rendered":"https:\/\/www.atlasrleye.com\/clinical-case-1\/"},"modified":"2024-01-27T15:35:40","modified_gmt":"2024-01-27T15:35:40","slug":"clinical-case-1","status":"publish","type":"page","link":"https:\/\/www.atlasrleye.com\/en\/age-related-macular-degeneration\/exudative-armd\/clinical-case-1\/","title":{"rendered":"Clinical Case 1"},"content":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”AGE-RELATED MACULAR DEGENERATION” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fatlas%2F%231635506431773-0d8d0743-1f0b|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ add_icon=”true” css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Exudative ARMD – Clinical Case 1″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fage-related-macular-degeneration%2Fexudative-armd%2F|title:Exudative%20ARMD|”]

<\/div>[\/vc_column][\/vc_row][vc_row][vc_column]
<\/div>
<\/div>[\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”23899″ img_size=”medium” add_caption=”yes” alignment=”center” onclick=”link_image”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

Fundus photograph of exudative age-related macular degeneration, in a 82-years-old male patient,<\/span><\/p>\n

showing severe macular hemorrhage that surrounds subretinal vascularized scar tissue.<\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”23902″ img_size=”medium” alignment=”center” onclick=”link_image”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

Fundus photograph, 7 weeks later, showing reabsorption of hemorrhage.<\/span><\/p>\n

The patient was injected 1 month ago with intraocular bevacizumab.<\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n

Evaluations
\n<\/span><\/h3>\n

[\/vc_column_text][vc_tta_accordion active_section=”99″ no_fill=”true” collapsible_all=”true”][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”1st Evaluation” tab_id=”1636641179216-cb4f444c-b7b1″][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Fluorescein Angiography<\/span><\/p>\n

\n

Fluorescein angiogram (early phase) shows macular leakage.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”27415,27418,27421,27424,27427,27379,27430″ img_size=”185*206″ css=”.vc_custom_1706368739893{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”27397″ img_size=”193*206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”27400″ img_size=”193*206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/span><\/p>\n

\n

Red-free photograph showing macular deformation.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”27394″ img_size=”193*206″ css=”.vc_custom_1706368660499{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Anterior Segment Photo<\/p>\n

\n

Visual acuity: 20\/25 RE; < 20\/400 LE.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”27382″ img_size=”323*206″ css=”.vc_custom_1706368562589{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/span><\/p>\n

\n

OCT vertical line-scan showing choroidal neovascular membrane and a deformed retinal structure. Note the subretinal fluid accumulation and subpigmentepithelial blood\/lipids.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”27403,27406,27409,27412″ img_size=”410*110″ css=”.vc_custom_1706368694890{margin-top: -30px !important;}”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/span><\/p>\n

\n

Ultra-widefield photograph .<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”27385,27388,27391″ img_size=”251*250″ css=”.vc_custom_1706368613638{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”2nd Evaluation” tab_id=”1683323894631-ffdbab8c-3de3″][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24061″ img_size=”193*206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24064″ img_size=”193*206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24058″ img_size=”193*206″][\/vc_column_inner][\/vc_row_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/span><\/p>\n

\n

1 month after intraocular bevacizumab injection.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24067,24040,24043,24046″ img_size=”307*110″ css=”.vc_custom_1706368827813{margin-top: -30px !important;}”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24049,24052,24055″ img_size=”251*250″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”AGE-RELATED MACULAR DEGENERATION” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fatlas%2F%231635506431773-0d8d0743-1f0b|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ add_icon=”true” css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Exudative ARMD – Clinical Case 1″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fage-related-macular-degeneration%2Fexudative-armd%2F|title:Exudative%20ARMD|”][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”23899″ img_size=”medium” add_caption=”yes” alignment=”center” onclick=”link_image”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text] Fundus […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":58096,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-30875","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/30875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/comments?post=30875"}],"version-history":[{"count":31,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/30875\/revisions"}],"predecessor-version":[{"id":94283,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/30875\/revisions\/94283"}],"up":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/58096"}],"wp:attachment":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/media?parent=30875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}